ENDEFR
Home › United States › GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP

Limited Partnership · BOSTON, United States · LEI 549300EC9IWPQT4CU957
LEI lapsed

Summary

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP is registered in the United States. Its legal form is Limited Partnership. According to GLEIF, its ultimate parent is SANOFI (France), and its direct parent is Genzyme Corporation (United States). That group has 76 subsidiaries with LEIs in 33 countries, 4 of them in the United States. The LEI was first issued on 2 Apr 2013 and the record was last updated on 9 Apr 2025. It has lapsed: renewal was due by 24 May 2019. AssetCensus found 3 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 24 May 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent link rests on accounts for the period ending 31 Mar 2018, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 9 Apr 2025.

Company details

Legal formLimited Partnership
Register · Register website
Registration number000912629
Registration authorityCorporations Division (Secretary of the Commonwealth's Office)
JurisdictionUnited States (US-MA)
Registered addressC/O CORPORATION SERVICE COMPANY, 84 STATE STREET, 02109 BOSTON, United States
Headquarters address84 State Street, 02109 Boston, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)23 Dec 2005
LEI549300EC9IWPQT4CU957
LEI statuslapsed
LEI first issued2 Apr 2013
LEI record last updated9 Apr 2025
Next LEI renewal24 May 2019
Corroboration of the LEI recordfully corroborated

Group membership

SANOFI France ultimate parent
Genzyme Corporation United States lapsed direct parent
GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP this entity
View the whole group: 76 subsidiaries in 33 countries

Relationship to the parent

Direct parentUltimate parent
ParentGenzyme CorporationSANOFI
Accounting period1 Apr 2017 to 31 Mar 20181 Apr 2017 to 31 Mar 2018
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start22 May 201824 May 2018
Recorded at GLEIF since2 Apr 20132 Apr 2013
Last updated9 Apr 20259 Apr 2025
Record statusnot renewednot renewed